Shigeta S, Mori S, Watanabe F, Takahashi K, Nagata T, Koike N, Wakayama T, Saneyoshi M
Department of Microbiology, School of Medicine, Fukushima Medical University, Japan.
Antivir Chem Chemother. 2002 Mar;13(2):67-82. doi: 10.1177/095632020201300201.
Twenty 5-alkyl-2-thiopyrimidine nucleosides were newly synthesized and examined for antiviral activities against herpes simplex virus (HSV), varicella-zoster virus (VZV) and human cytomegalovirus (HCMV). In this study, 2'-deoxy-5-alkyl-2-thiocytidine analogues had lower 50% effective concentration (EC50) values against HSV-1, and 2'-deoxy-5-alkyl-2-thiouridine analogues showed lower EC50 against VZV than their congeners of arabinoside form. Among the compounds examined, 2'-deoxy-5-ethyl and 5-propyl-2-thiocytidine (TN-53 and TN-54) were most potent and selective anti-HSV compounds. Their EC50s were 0.04 and 0.15 microM, and selectivity indexes were more than 7,215 and 1,849, respectively. On the other hand, 2'-deoxy-5-propyl-2-thiouridine (TN-51), 5-bromovinyl-2-thiouracil arabinoside (TN-65) and 5-styryl-2-thiouracil arabinoside (TN-67) were most potent and selective anti-VZV compounds. Their EC50s were 3.1, 3.8 and 2.6 pM for CaQu strain of VZV, respectively, and 2.1 to 3.0 times lower than that of acyclovir. All 2-thiopyrimidine nucleoside analogues did not show antiviral activities against thymidine kinase (TK) negative strains of HSV-1 and VZV. Only three 2-thiocytosine arabinoside compounds showed marginal anti-CMV activities (EC50s were 57-159 pM). All of the five alkyl-2-thio-pyrimidine nucleoside analogues examined were not cytotoxic to human lymphoblastoid cells (RPM18226) and human embryonic fibroblast cells (MRC-5) at 240 microM (100 microg/ml) or more. Regarding the structure-activity relationship of 5-alkyl-2-thiopyrimidine nucleoside analogues, the following remarks will be noted. Elongation of 5-alkyl chain (methyl to ethyl) of 2-thiocytosine in both deoxyribosyl and arabinosyl nucleosides increased anti-HSV-1 activity but not anti-VZV activity. Furthermore, elongation of the same chain (ethyl to propyl) of 2-thiodeoxyuridine increased anti-VZV activity whereas it did not in the case of 2-thiouracil arabinosides.
新合成了20种5-烷基-2-硫代嘧啶核苷,并检测了它们对单纯疱疹病毒(HSV)、水痘带状疱疹病毒(VZV)和人巨细胞病毒(HCMV)的抗病毒活性。在本研究中,2'-脱氧-5-烷基-2-硫代胞苷类似物对HSV-1的50%有效浓度(EC50)值较低,且2'-脱氧-5-烷基-2-硫代尿苷类似物对VZV的EC50低于其阿拉伯糖苷形式的同类物。在所检测的化合物中,2'-脱氧-5-乙基和5-丙基-2-硫代胞苷(TN-53和TN-54)是最有效的选择性抗HSV化合物。它们的EC50分别为0.04和0.15微摩尔,选择性指数分别超过7215和1849。另一方面,2'-脱氧-5-丙基-2-硫代尿苷(TN-51)、5-溴乙烯基-2-硫代尿嘧啶阿拉伯糖苷(TN-65)和5-苯乙烯基-2-硫代尿嘧啶阿拉伯糖苷(TN-67)是最有效的选择性抗VZV化合物。它们对VZV的CaQu株的EC50分别为3.1、3.8和2.6皮摩尔,比阿昔洛韦低2.1至3.0倍。所有2-硫代嘧啶核苷类似物对HSV-1和VZV的胸苷激酶(TK)阴性株均无抗病毒活性。只有三种2-硫代胞嘧啶阿拉伯糖苷化合物表现出微弱的抗CMV活性(EC50为57-159皮摩尔)。所检测的五种烷基-2-硫代嘧啶核苷类似物在240微摩尔(100微克/毫升)或更高浓度下对人淋巴母细胞(RPM18226)和人胚成纤维细胞(MRC-5)均无细胞毒性。关于5-烷基-2-硫代嘧啶核苷类似物的构效关系,需注意以下几点。在脱氧核糖核苷和阿拉伯糖核苷中,2-硫代胞嘧啶的5-烷基链(从甲基到乙基)延长可增加抗HSV-1活性,但不增加抗VZV活性。此外,2-硫代脱氧尿苷的同一链(从乙基到丙基)延长可增加抗VZV活性,而2-硫代尿嘧啶阿拉伯糖苷则不然。